Onward Medical N.V. (FRA:63E)

Germany flag Germany · Delayed Price · Currency is EUR
4.020
-0.025 (-0.62%)
Last updated: Dec 4, 2025, 3:29 PM CET
-8.84%
Market Cap 181.42M
Revenue (ttm) 2.72M
Net Income (ttm) -38.65M
Shares Out n/a
EPS (ttm) -0.78
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume n/a
Average Volume n/a
Open 4.120
Previous Close 4.045
Day's Range 4.020 - 4.120
52-Week Range 3.490 - 7.180
Beta n/a
RSI 43.62
Earnings Date Nov 24, 2025

About Onward Medical

Onward Medical N.V., a medical technology company, develops and commercializes therapies to enable functional recovery for people with Spinal Cord Injury (SCI). The company engages in developing ARCEX, a technology to enhance hand strength and sensation for individuals with SCI; ARCIM, a spinal cord stimulation system designed to address blood pressure instability and other symptoms in people with SCI; ARCBCI, an implanted brain-computer interface to restore thought-driven movement. It operates in France, Germany, the Netherlands, the United Ki... [Read more]

Industry Surgical and Medical Instruments and Apparatus
Founded 2014
Employees 103
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol 63E
Full Company Profile

Financial Performance

In 2024, Onward Medical's revenue was 1.74 million, an increase of 226.88% compared to the previous year's 532,000. Losses were -35.73 million, -1.26% less than in 2023.

Financial Statements

News

There is no news available yet.